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Conclusion: HPV DNA detection in both the palatine and pharyngeal tonsils 
in the same individual, especially in HPV-OPC, suggested the ability of HPV 
to infect tonsillar tissues of Waldeyer’s ring multifocally. 
Background: Multifocal human papillomavirus (HPV) infection into the 
palatine and pharyngeal tonsils, which might be linked to a second primary 
tumor of HPV-positive oropharyngeal cancer (OPC), was investigated. 
Patients and methods: One hundred and five patients with various head and 
neck diseases including 14 patients with OPC were enrolled in this study. 
Swabs from the palatine and pharyngeal tonsils were collected in each 
individual, and auto-nested GP5+/GP6+ PCR for HPV DNA was performed. 
Results: HPV DNA was detected in the palatine tonsil or the pharyngeal 
tonsil in a small subset of upper respiratory tract cancer other than OPC 
(URTC) and non-cancer diseases. Furthermore, HPV DNA was detected in 
both the palatine and pharyngeal tonsils in the same individual in 2 of 48 
(4%) URTC cases, and 1 of 43 (2%) non-cancer cases. On the other hand, 
p16-positive OPC cases demonstrated a higher HPV DNA detection rate (4 of 
9, 44.4%) compared with other disease groups. 
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Introduction 
Human papillomavirus (HPV) infection is a principal cause of a distinct 
form of oropharyngeal cancer (OPC) [1]. The incidence of HPV-positive OPC 
(HPV-OPC) has been increasing, and it accounted for 72% of all OPCs in the 
early 2000s in the United States [2]. Interestingly, the clinical characteristics 
of HPV-OPC are quite different from classic HPV-negative OPC [1]. Some 
major interesting characteristics of HPV-OPC include the predominant 
occurrence in the palatine tonsil followed by the lingual tonsil, and a reduced 
risk of developing second primary cancer compared with classic OPC [3]. 
On the other hand, there are interesting case reports showing synchronous 
HPV-related bilateral tonsillar cancers [4,5]. Furthermore, McGovern et al. 
demonstrated a case with three synchronous HPV-positive cancers of the 
bilateral tonsils as well as the nasopharynx [6]. Therefore, multifocal HPV 
infection into Waldeyer’s ring including the palatine tonsils, pharyngeal 
tonsil, and lingual tonsil may be possible. However, there have been few 
reports from this perspective [7]. In the present study, we compared the 
incidence of HPV infection between the palatine and pharyngeal tonsils in 
the same individuals in a group of patients with various head and neck 
diseases including OPC. 
 
Patients and methods 
Patients 
One hundred and five patients with various head and neck diseases 
including 14 OPCs were enrolled in this study. They were divided into three 
groups: OPC, upper respiratory tract cancer other than OPC (URTC), and 
non-cancer. The clinical characteristics of the patients are shown in Table 1. 
URTC included 15 laryngeal cancers, 13 hypopharyngeal cancers, 9 oral 
cancers, 8 nasopharyngeal cancers, and 3 others. Non-cancer included 15 
sinonasal diseases except for papilloma, 8 benign thyroid tumors, 7 benign 
laryngeal diseases except for papilloma, 7 ear diseases, 3 benign salivary 
gland tumors, and 3 others. This study was approved by the Ethics 
Committee of Kanazawa University School of Medicine (2014-054), and 
Fukushima Medical University (2996), and written consent was obtained 
from all enrolled patients. 
Actually, enrolled patients in this study also comprised the majority of 
subjects in a previous study simultaneously performed [8]. Some data in the 
previous study, namely, patient characteristics, HPV detection and 
genotyping in the palatine tonsil, and p16 immunostaining, were utilized in 
the present study [8]. However, as described above, the present study focused 
on comparing HPV infection between the palatine and pharyngeal tonsils, 
contrasting with the previous report focusing on HPV detection in oral rinse 
as a biomarker of OPC [8]. 
Sample collection 
With respect to the sample from the palatine tonsil, brushing of the 
palatine tonsil using a swab for uterine cervix cytodiagnosis was performed 
[8]. Brushing was basically performed on the surface of the palatine tonsil 
while it was performed on the tumor-harboring palatine tonsil in cases with 
tonsillar cancer. With respect to the sample from the pharyngeal tonsil, 
brushing was endonasally performed using a swab with a movable cover 
allowing exposure only in the nasopharynx to prevent endonasal 
contamination. Samples were stored at 4 degrees Celsius until use after 
being suspended in a preservative solution for liquid-based cytology (Medical 
& Biological Laboratories, Nagoya, Japan). 
HPV DNA detection 
DNA extraction and HPV DNA detection were performed as reported 
previously [8]. Briefly, after DNA extraction, β-Globin was first amplified by 
the polymerase chain reaction (PCR) to confirm the adequacy of the 
extracted DNA in all samples. In β-globin-positive samples, auto-nested PCR 
consisting of the first amplification with 36 cycles and the second with 20 
cycles using the same set of GP5+/GP6+ primers to increase sensitivity was 
performed to detect a broad spectrum of mucosotropic HPV [8-12]. This 
generates an approximately 140-bp-long fragment from the HPV L1 
structural gene. The amplified DNA was visualized by ultraviolet 
illumination using ethidium bromide after electrophoresis on 2% agarose gel. 
The p1203 PML2d HPV-16 plasmid, which was a gift from Peter Howley 
(Addgene plasmid # 10869), was used as a positive control, while the 
negative control included all reagents except for DNA. 
HPV genotyping 
HPV genotyping, which could detect 37 HPV genotypes including 15 
high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68), 6 
low-risk types (6, 11, 42, 43, 44, and CP8304), and 16 probably low-risk types 
(26, 34, 40, 54, 55, 57, 61, 67, 69, 70, 71, 72, 73, 82, 83, and 84) was performed 
for HPV DNA-positive samples as previously described [8]. 
Immunohistochemistry 
In 14 OPC cases, previously reported data on immunostaining for p16 was 
also utilized in this study [8].  
Statistical analysis 
The distribution of HPV DNA between the palatine and pharyngeal 
tonsils was analyzed using the two-tailed Fisher’s exact test. All analyses 
were carried out using SPSS19.0 software (SPSS Inc., Chicago, IL, USA). In 
all tests, p<0.05 was considered significant. 
 
Results  
HPV DNA detection in the palatine and pharyngeal tonsils 
β-Globin was detected in all samples. In 14 cases with OPC, HPV DNA was 
detected in 3 cases (21%) in only the palatine tonsil, 1 case (7%) in only the 
pharyngeal tonsil, 4 cases (29%) in both the palatine and pharyngeal tonsils, 
and 6 cases (43%) in neither the palatine nor pharyngeal tonsil (Table 2, 
Figure). In 9 cases with p16-positive OPC, HPV DNA was detected in 3 cases 
(33%), none (0%), 4 cases (44%), and 2 cases (22%), respectively. In 5 cases 
with p16-negative OPC, HPV DNA was detected in none (0%), 1 case (20%), 
none (0%), and 4 cases (80%), respectively. 
In 48 cases with URTC, HPV DNA was detected in 2 cases (4%) in only the 
palatine tonsil, 2 cases (4%) in only the pharyngeal tonsil, 2 cases (4%) in 
both the palatine and pharyngeal tonsils, and 42 cases (88%) in neither the 
palatine nor pharyngeal tonsil (Table 2, Figure). All these 6 cases with HPV 
detection, including one nasopharyngeal cancer, two hypopharyngeal cancers, 
two oral cancers, and one cervical node cancer of unknown primary, were 
negative for p16 immunostaining. Similarly, in 43 cases with non-cancer, 
HPV DNA was detected in 3 cases (7%), 4 cases (9%), 1 case (2%), and 35 
cases (81%), respectively (Table 2, Figure). 
HPV genotyping 
HPV genotyping was further performed in 29 samples with HPV DNA 
detection. In p16-positive OPC, HPV58 was detected in one case positive for 
only the palatine tonsil. Two cases positive for both the palatine and 
pharyngeal tonsils demonstrated HPV16 in each sample. In URTC, one of 
two cases positive for only the pharyngeal tonsil showed HPV16. This was a 
case with oral cancer. Another case positive for both tonsils showed HPV16 
in the pharyngeal tonsil while no genotype was detectable in the palatine 
tonsil. This was a case with hypopharyngeal cancer. In non-cancer cases, two 
of three cases positive for only the palatine tonsil demonstrated HPV16. No 
types of HPV were detected in the remaining samples of each disease group. 
 
Discussion 
In the present study, HPV DNA was detected in 4 of 48 cases (8.3%) in the 
palatine tonsil and also 4 of 48 cases (8.3%) in the pharyngeal tonsil in 
patients with URTC. Similarly, HPV DNA was detected in 4 of 43 cases 
(9.3%) in the palatine tonsil and 5 of 43 cases (11.6%) in the pharyngeal 
tonsil in patients with non-cancer. A few reports comparing HPV detection in 
those two tissues are currently available [13,14]. Although these reports 
analyzed HPV DNA using GP5+/GP6+ primers or MY09/MY11 primers in 
paraffin-embedded tonsillar and adenoid tissues of children, the results were 
conflicting [13,14]. The former demonstrated HPV detection in 9.4% in the 
palatine tonsil and in 7.1% in the pharyngeal tonsil, while the latter showed 
HPV detection in neither the palatine nor pharyngeal tonsil [13,14]. 
Although it is possible that the quantity of DNA obtained from a swab is less 
than from paraffin-embedded tissue, an HPV detection rate in the present 
study equivalent to that in the report by Mammas et al. in both tissues may 
be due to using auto-nested GP5+/GP6+ PCR like our previous report in oral 
rinse [8]. Of course, the fact that subjects in the present study were adult 
may also affect it. 
The present study demonstrated that HPV infection is possible solely in 
either the palatine tonsil or pharyngeal tonsil as well as multifocally in both 
tonsils. It remains unknown whether HPV infection of those tissues is 
passive or oncogenic. Although several reports demonstrated HPV detection 
in a small subset of nasopharyngeal cancer (NPC), most HPV-related head 
and neck cancers belong to OPC [1,15,16]. Therefore, the greater 
predominance of OPC than NPC in the association with HPV, despite the 
similar HPV detectability between both tonsils in the present study, suggests 
that HPV infection could be rarely oncogenic in the pharyngeal tonsil, but be 
possibly oncogenic in the palatine tonsil. Structural differences between both 
tonsils may be one of the reasons for such a predominance [17]. HPV-OPC 
generally arises from deep crypts of the palatine tonsil. Interestingly, 
palatine tonsillar crypts, blind tubules from the epithelium on the surface of 
the tonsil, extend deeply into this tissue [17]. On the other hand, unlike the 
palatine and lingual tonsils, the pharyngeal tonsils have no epithelial crypts 
extending into them [17]. 
Multifocal HPV infection into both the palatine and pharyngeal tonsils 
was observed in the present study, especially in p16-positive OPC rather 
than URTC and non-cancer. This is an interesting finding because an 
HPV-associated second primary tumor of HPV-OPC may present 
synchronously and/or metachronously outside the oropharynx [6,18]. 
Virus-induced field cancerization and/or multifocal oncogenic HPV infection 
of the pharynx is considered uncommon in OPC because both HPV-positive 
and HPV-negative tonsil cancers similarly harbor HPV infection at other 
pharyngeal sites [7]. However, in the report by Thavaraj et al., three of 12 
other pharyngeal sites with HPV infection, which accounted for 3 of 59 cases 
as a result, demonstrated p16 positivity as well as a histology of severe 
dysplasia in HPV-positive tonsillar cancer, while none of such sites showed 
them in HPV-negative tonsillar cancer [7]. This suggests that multifocal 
HPV infection in tonsils of Waldyer’s ring could be oncogenic, at least in part. 
In accordance with this, Joseph et al. reported that all 4 synchronous or 
metachronous bilateral HPV-associated tonsillar cancers demonstrated 
100% concordance of the HPV DNA sequence in each pair of the index tumor 
and corresponding second primary tumor [19]. Therefore, we believe that the 
importance of multifocal infection of HPV from the perspective of 
multicentric cancerization in HPV-OPC should be emphasized. 
 There are several limitations in the present study. Firstly, the number of 
cases with OPC was small. However, the high HPV DNA detection rate in 
the cancer-harboring palatine tonsil suggested that our procedure was 
adequate. Therefore, we could at least demonstrate a trend toward a higher 
rate of HPV infection into the pharyngeal tonsil in HPV-OPC (44.3%) 
compared with URTC (8.3%) and non-cancer (11.6%). Secondly, the 
contralateral normal-appearing tonsil should have been investigated in 
addition to the index cancer-harboring tonsil in cases of OPC. This would 
have provided us with further information with respect to multifocal HPV 
infection into Waldeyer’s ring. Thirdly, although we made up for the 
disadvantage of the small quantity of each sample with the use of 
auto-nested PCR, as previously shown, we could not evaluate the histology 
including presence of cancer or dysplasia nor p16 immunoreactivity in cases 
with HPV DNA detection [8]. Prospective observation including histology if 
necessarily will be helpful to confirm an oncogenic role of HPV infection for 
the second primary tumor in OPC. Fourthly, the HPV genotyping rate was 
low. We considered the procedural difference between genotyping, which 
consisted of one round of PCR, and auto-nested PCR was a major reason for 
the low rate [8]. However, at least a trend of HPV16 predominance was 
confirmed. Further study is planned to overcome these limitations. 
 
Conclusion 
In conclusion, HPV DNA detection in both the palatine and pharyngeal 
tonsils in the same individual, especially in those with HPV-OPC, suggested 
the ability of HPV to infect tonsillar tissues of Waldeyer’s ring multifocally. 
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 Representative images of HPV DNA detection. HPV DNA was detected in 
both the palatine tonsil (Pal) and pharyngeal tonsil (Pha) in a p16-positive 
oropharyngeal cancer (OPC) case (1st panel), and in only Pha in a 
p16-negative OPC case (6th panel). HPV DNA was detected in both Pal and 
Pha in an upper respiratory tract cancer other than OPC (URTC) case (2nd 
panel), and in only Pha in another URTC case (3rd panel). HPV DNA was 
detected in both Pal and Pha in a non-cancer case (4th panel), and in only 
Pha in another non-cancer case (5th panel). Six lanes belonging to another 
disease group in each gel were removed from the original image in each 
panel. PC, positive control; NC, negative control; OR, oral rinse. * means a 
blank lane. 
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